Kite’s CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL) Read more
Bertis Announces Proteomic Based Research Results of New Biomarker for Ovarian Cancer Diagnosis Read more
Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes Read more
CARsgen Releases the First Clinical Batch of CAR T Cells from its RTP GMP Manufacturing Facility in North Carolina Read more
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF KONVOMEP (omeprazole and sodium bicarbonate for oral suspension) Read more
Vertex Announces FDA Approval for ORKAMBI (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months Read more
Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer Read more
FDA approves the first treatment option for generalized pustular psoriasis flares in adults Read more